niclosamide has been researched along with Asthma, Bronchial in 2 studies
Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ousingsawat, J | 1 |
| Centeio, R | 1 |
| Cabrita, I | 2 |
| Talbi, K | 1 |
| Zimmer, O | 1 |
| Graf, M | 1 |
| Göpferich, A | 1 |
| Schreiber, R | 2 |
| Kunzelmann, K | 2 |
| Benedetto, R | 1 |
2 other studies available for niclosamide and Asthma, Bronchial
| Article | Year |
|---|---|
Airway Delivery of Hydrogel-Encapsulated Niclosamide for the Treatment of Inflammatory Airway Disease.
Topics: Animals; Asthma; Cells, Cultured; COVID-19; COVID-19 Drug Treatment; Disease Models, Animal; Drug Ca | 2022 |
Niclosamide repurposed for the treatment of inflammatory airway disease.
Topics: Animals; Anoctamins; Anti-Inflammatory Agents; Asthma; Bronchi; Cell Line, Tumor; Cystic Fibrosis; D | 2019 |